---
figid: PMC5449256__nihms852287f1
figlink: /pmc/articles/PMC5449256/figure/F1/
number: Figure 1
caption: EGFR stimulation induces activation of phosphatase SHP2 which decreases phosphorylation
  of STAT1 and subsequently expression of HLA class I and APM components. Conversely,
  EGFR mediated activation of JAK2-STAT1 induces expression of PD-L1. Likewise, mutant
  EGFR/RAS-MAPK pathway induces expression of PD-L1 as reported in NCSLC. Other pathways
  involved in PD-L1 expression are depicted on the left, PI3K and NPM/ALK-STAT3 pathways
  have been reported to upregulate PD-L1 in glioblastoma and T cell Lymphoma, respectively.
  EGFR/HER2 stimulation induces secretion of IL-8, IL-6, CCL2, CCL3, CCL5, eotaxin,
  GM-CSF inducing chronic inflammation and escape from T cell recognition. Overall,
  EGFR mediated downregulation of signal 1 and upregulation of suppressive signals
  2 and 3, favoring escape from CTL recognition.
pmcid: PMC5449256
papertitle: Oncogenic growth factor signaling mediating tumor escape from cellular
  immunity.
reftext: Fernando Concha-Benavente, et al. Curr Opin Immunol. ;45:52-59.
pmc_ranked_result_index: '155704'
pathway_score: 0.9485081
filename: nihms852287f1.jpg
figtitle: Oncogenic growth factor signaling mediating tumor escape from cellular immunity
year: ''
organisms: Homo sapiens
ndex: cca3a8aa-def6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5449256__nihms852287f1.html
  '@type': Dataset
  description: EGFR stimulation induces activation of phosphatase SHP2 which decreases
    phosphorylation of STAT1 and subsequently expression of HLA class I and APM components.
    Conversely, EGFR mediated activation of JAK2-STAT1 induces expression of PD-L1.
    Likewise, mutant EGFR/RAS-MAPK pathway induces expression of PD-L1 as reported
    in NCSLC. Other pathways involved in PD-L1 expression are depicted on the left,
    PI3K and NPM/ALK-STAT3 pathways have been reported to upregulate PD-L1 in glioblastoma
    and T cell Lymphoma, respectively. EGFR/HER2 stimulation induces secretion of
    IL-8, IL-6, CCL2, CCL3, CCL5, eotaxin, GM-CSF inducing chronic inflammation and
    escape from T cell recognition. Overall, EGFR mediated downregulation of signal
    1 and upregulation of suppressive signals 2 and 3, favoring escape from CTL recognition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD274
  - MAPK10
  - MAPK13
  - MAPK12
  - NPM1
  - PTEN
  - HRAS
  - MAPK3
  - MAPK8
  - MAPK9
  - STAT1
  - STAT3
  - EGF
  - EGFR
  - CSF3
  - ERBB2
  - MAPK14
  - ALK
  - KRAS
  - MAPK1
  - CCL5
  - JAK2
  - IL6
  - CCL2
  - MAPK11
  - PTPN11
  - NRAS
  - CXCL8
  - Cancer
  - Lung cancer
genes:
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: NPM/ALK
  symbol: NPM
  source: hgnc_alias_symbol
  hgnc_symbol: NPM1
  entrez: '4869'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RAS/
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR/
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: G-CSF
  symbol: G-CSF
  source: hgnc_prev_symbol
  hgnc_symbol: CSF3
  entrez: '1440'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: LymphomaNPM/ALK
  symbol: ALK
  source: hgnc_symbol
  hgnc_symbol: ALK
  entrez: '238'
- word: RAS/
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CCL5,
  symbol: CCL5
  source: hgnc_symbol
  hgnc_symbol: CCL5
  entrez: '6352'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: IL-6,G-CSF
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: CCL2,
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: SHP2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: RAS/
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: IL-8,
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
